These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 28378904)
21. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Ben-Ami R; Berman J; Novikov A; Bash E; Shachor-Meyouhas Y; Zakin S; Maor Y; Tarabia J; Schechner V; Adler A; Finn T Emerg Infect Dis; 2017 Feb; 23(1):195-203. PubMed ID: 28098529 [TBL] [Abstract][Full Text] [Related]
22. A Fatal Case of Candida auris and Candida tropicalis Candidemia in Neutropenic Patient. Mohd Tap R; Lim TC; Kamarudin NA; Ginsapu SJ; Abd Razak MF; Ahmad N; Amran F Mycopathologia; 2018 Jun; 183(3):559-564. PubMed ID: 29383574 [TBL] [Abstract][Full Text] [Related]
23. First report of sporadic cases of Candida auris in Colombia. Parra-Giraldo CM; Valderrama SL; Cortes-Fraile G; Garzón JR; Ariza BE; Morio F; Linares-Linares MY; Ceballos-Garzón A; de la Hoz A; Hernandez C; Alvarez-Moreno C; Le Pape P Int J Infect Dis; 2018 Apr; 69():63-67. PubMed ID: 29421668 [TBL] [Abstract][Full Text] [Related]
24. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp. Chiew YF; Inwood H N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112 [No Abstract] [Full Text] [Related]
25. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Prakash A; Sharma C; Singh A; Kumar Singh P; Kumar A; Hagen F; Govender NP; Colombo AL; Meis JF; Chowdhary A Clin Microbiol Infect; 2016 Mar; 22(3):277.e1-9. PubMed ID: 26548511 [TBL] [Abstract][Full Text] [Related]
26. Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing. Araúz AB; Caceres DH; Santiago E; Armstrong P; Arosemena S; Ramos C; Espinosa-Bode A; Borace J; Hayer L; Cedeño I; Jackson BR; Sosa N; Berkow EL; Lockhart SR; Rodriguez-French A; Chiller T Mycoses; 2018 Jan; 61(1):44-47. PubMed ID: 28945325 [TBL] [Abstract][Full Text] [Related]
35. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Baily GG; Moore CB; Essayag SM; de Wit S; Burnie JP; Denning DW Clin Infect Dis; 1997 Jul; 25(1):161-3. PubMed ID: 9243058 [No Abstract] [Full Text] [Related]
36. Background changing patterns of neonatal fungal sepsis in a developing country. Ballot DE; Bosman N; Nana T; Ramdin T; Cooper PA J Trop Pediatr; 2013 Dec; 59(6):460-4. PubMed ID: 23803724 [TBL] [Abstract][Full Text] [Related]
37. A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser. Vervaeke S; Vandamme K; Boone E; De Laere E; Swinne D; Surmont I Med Mycol; 2008 Dec; 46(8):853-6. PubMed ID: 18798049 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp. Kim TH; Lee MK Clin Chem Lab Med; 2010 Feb; 48(2):297-8. PubMed ID: 20131969 [No Abstract] [Full Text] [Related]
39. Methods for identification of Candida auris, the yeast of global public health concern: A review. Mahmoudi S; Agha Kuchak Afshari S; Aghaei Gharehbolagh S; Mirhendi H; Makimura K J Mycol Med; 2019 Jun; 29(2):174-179. PubMed ID: 31031132 [TBL] [Abstract][Full Text] [Related]